As the above results interestingly identified C/EBPβ K134 SUMOylation negatively regulate C/EBPβ protein level and improve cardiac hypertrophy, while C/EBPβ PARylation positively affect C/EBPβ protein level and aggravate cardiac hypertrophy. The gene discussed is CEBPB; the disease is cardiac hypertrophy.